Free Trial
NASDAQ:OFIX

Orthofix Medical Q3 2026 Earnings Date & Estimates

Orthofix Medical logo
$9.07 0.00 (0.00%)
Closing price 10/30/2026 04:00 PM Eastern
Extended Trading
$9.53 +0.46 (+5.12%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Orthofix Medical is scheduled to report Q3 2026 earnings on Monday, November 9, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET

What Analysts Expect from Orthofix Medical in Q3 2026

Orthofix Medical is expected to post earnings of $0.11 per share on revenue of $210.52 million. Orthofix Medical last reported on August 5, 2026, posting -$0.39 per share and beating the -$0.4099 consensus estimate. Orthofix Medical has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.11
Expected Revenue
$210.52 million

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.39 (Beat by +$0.0199)
Last Quarter Revenue
$210.93 million
EPS Beat Rate
3 of last 8 quarters

Orthofix Medical Q3 2026 Earnings FAQ

Orthofix Medical (NASDAQ:OFIX) has confirmed it will report Q3 2026 earnings on Monday, November 9, 2026, before market opens.

Orthofix Medical's Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Orthofix Medical to post earnings of $0.11 per share for Q3 2026.

The consensus revenue estimate for Orthofix Medical is $210.52 million for Q3 2026.

Orthofix Medical Earnings Headlines

Orthofix to Report Third Quarter 2026 Financial Results
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.tc pixel
Orthofix pays former executives $24M in damages
See More Orthofix Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Orthofix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orthofix Medical and other key companies, straight to your email.

About Orthofix Medical

Orthofix Medical (NASDAQ:OFIX) is a medical device company focused on spinal and orthopedic solutions. The company develops, manufactures and distributes products designed to help treat spinal disorders, support bone healing and address orthopedic trauma and related musculoskeletal conditions.

Its product portfolio includes spinal fixation and interbody systems, biologics and bone-grafting products, bone growth stimulation devices, and technologies for spinal motion preservation and deformity correction. Orthofix also offers orthopedic trauma products, including systems used in fracture treatment and limb reconstruction. Its brands and product lines serve a range of surgical and non-surgical treatment needs.

Orthofix has roots dating to the 1980s and expanded its spine business through its combination with SeaSpine Holdings, completed in 2023. The combined company serves hospitals, health systems, surgeons and distributors in the United States and international markets, with products marketed through direct sales and distribution networks.

View Orthofix Medical Profile